Back to Journals » Cancer Management and Research » Volume 12
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,247 | Dovepress* | 6,795+ | 1,007 | 7,802 | |
PubMed Central* | 452 | 214 | 666 | ||
Totals | 7,247 | 1,221 | 8,468 | ||
*Since 21 January 2020 |
View citations on PubMed Central and Google Scholar